PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $74,868 | -12.5% | 24,229 | +19.8% | 0.00% | 0.0% |
| Q4 2022 | $85,522 | -25.0% | 20,218 | +63.2% | 0.00% | -50.0% |
| Q2 2021 | $114,000 | +11.8% | 12,385 | +17.5% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -5.6% | 10,539 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $108,000 | +1.9% | 10,539 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $106,000 | -3.6% | 10,539 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $110,000 | +23.6% | 10,539 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $89,000 | -80.9% | 10,539 | -80.2% | 0.01% | -82.9% |
| Q4 2019 | $466,000 | -32.9% | 53,289 | -17.4% | 0.04% | -35.9% |
| Q3 2019 | $695,000 | -75.1% | 64,532 | +102.3% | 0.06% | -89.0% |
| Q2 2017 | $2,788,000 | – | 31,900 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |